# Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma

> **NCT01979276** · PHASE1,PHASE2 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 4 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Romidepsin
- **DRUG:** pomalidomide
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01979276
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** this study was terminated due to losing financial support, and enrollment challenges
- **Last updated:** 2018-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01979276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01979276, "Study of Pomalidomide, Dexamethasone, and Romidepsin for Rel/Ref Myeloma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01979276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*